Differential Expression and Pathway Analysis in Drug-Resistant Triple-Negative Breast Cancer Cell Lines Using RNASeq Analysis

Triple-negative breast cancer (TNBC) is among the most notorious types of breast cancer, the treatment of which does not give consistent results due to the absence of the three receptors (estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) as well...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaheen, Safa, Fawaz, Febin, Shah, Shaheen, Büsselberg, Dietrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032108/
https://www.ncbi.nlm.nih.gov/pubmed/29921827
http://dx.doi.org/10.3390/ijms19061810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032108/
https://www.ncbi.nlm.nih.gov/pubmed/29921827
http://dx.doi.org/10.3390/ijms19061810

Ejemplares similares